Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02176694
Other study ID # 2013-1184
Secondary ID 1R21HL119826-01
Status Completed
Phase N/A
First received June 9, 2014
Last updated June 9, 2016
Start date June 2014
Est. completion date December 2015

Study information

Verified date June 2016
Source Children's Hospital Medical Center, Cincinnati
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

A randomized controlled trial of a texting intervention to increase adherence to preventative asthma medication in four Cincinnati Children's Hospital Medical Center primary care clinics.


Description:

Our first aim is to determine the feasibility, acceptability and use of a low intensity text messaging intervention to improve adherence to inhaled corticosteroid (ICS) therapy among high risk adolescents with persistent asthma. Our second aim is to determine effect sizes of the intervention to improve adherence (As measured by electronic monitoring and self-report); clinical asthma control; and asthma related quality of life among adolescents with persistent asthma. Our third and final aim is to determine the temporal relationship between text message receipt and ICS canister actuation in order to understand mechanisms by which text messaging may increase ICS adherence.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 21 Years
Eligibility Inclusion Criteria:

- provider-diagnosed persistent asthma

- prescription of an ICS in accordance in NHLBI Expert Panel Report 3 guidelines for at least 30 days prior to enrollment

- Asthma Control Test (ACT) score less than 20 (indicating lack of current control)

- no provider-diagnosed exacerbation in the 30 days prior to enrollment

- possession of a text-enabled cell phone and a plan to keep it throughout the study period

- agreement by parents (or participants over 18 years old) to any charges levied by their cell phone carrier for text messages associated with the study if they do not have an unlimited texting plan

- speak and read English

Exclusion Criteria:

- another chronic lung disease (which would complicate measurement of asthma control)

- cognitive or psychiatric disorder that the treating clinician judges would impair study participation

- use of Advair diskus for their ICS (for which no reliable electronic monitor exists)

- current enrollment in another asthma intervention study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Behavioral:
Text Messaging
Website that allows adolescents to create, schedule and send one-time or recurring text messages that will serve as a reminder to take asthma medication or follow up with another health-related matter.

Locations

Country Name City State
United States Cincinnati Children's Hospital Medical Center Cincinnati Ohio

Sponsors (2)

Lead Sponsor Collaborator
Children's Hospital Medical Center, Cincinnati National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Objective Adherence to ICS Electronic monitor logs Baseline No
Primary Change in objective adherence to ICS Electronic Monitor Logs Change from baseline in objective adherence to ICS at 1 month No
Primary Change in objective adherence to ICS Electronic Monitor Logs Continuous change over time from baseline in objective adherence to ICS at 2 months in intervention compared to control No
Primary Change in objective adherence to ICS Electronic Monitor Logs Continuous change over time from baseline in objective adherence to ICS at 3 months in intervention compared to control No
Primary Change in objective adherence to ICS Electronic Monitor Logs Continuous change over time from baseline in objective adherence to ICS at 4 months in intervention compared to control No
Primary Change in objective adherence to ICS Electronic Monitor Logs Continuous change over time from baseline in objective adherence to ICS at 5 months in intervention compared to control No
Primary Feasibility, Acceptability and Usability of the Text Messaging Website The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs. At time of text messaging intervention No
Primary Feasibility, Acceptability and Usability of the Text Messaging Website The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs. up to 1 month after receiving text messages No
Primary Feasibility, Acceptability and Usability of the Text Messaging Website The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs. up to 2 months after receiving text messages No
Primary Feasibility, Acceptability and Usability of the Text Messaging Website The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs. up to 3 months after receiving text messages No
Secondary Asthma Control The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. Baseline No
Secondary Change in Asthma Control The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. Change from Baseline at 1 month No
Secondary Change in Asthma Control The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. Continuous change over time from baseline at 2 months in intervention compared to control No
Secondary Change in Asthma Control The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. Continuous change over time from baseline at 3 months in intervention compared to control No
Secondary Change in Asthma Control The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. Continuous change over time from baseline at 4 months in intervention compared to control No
Secondary Change in Asthma Control The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. Continuous change over time from baseline at 5 months in intervention compared to control No
Secondary Asthma Symptoms, Quality of Life, Treatment Barriers The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. Baseline No
Secondary Change in Asthma Symptoms, Quality of Life, Treatment Barriers The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. Change from Baseline at month 1 No
Secondary Change in Asthma Symptoms, Quality of Life, Treatment Barriers The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. Continuous change over time from baseline at 2 months in intervention compared to control No
Secondary Change in Asthma Symptoms, Quality of Life, Treatment Barriers The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. Continuous change over time from baseline at 3 months in intervention compared to control No
Secondary Change in Asthma Symptoms, Quality of Life, Treatment Barriers The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. Continuous change over time from baseline at 4 months in intervention compared to control No
Secondary Change in Asthma Symptoms, Quality of Life, Treatment Barriers The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. Continuous change over time from baseline at 5 months in intervention compared to control No
See also
  Status Clinical Trial Phase
Completed NCT02513160 - Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma Phase 3
Active, not recruiting NCT02883530 - Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study
Completed NCT02003521 - Impact of Lung Flute Therapy on Asthma N/A
Completed NCT01253603 - Efficacy, Safety, and Pharmacokinetics of QAW039 Phase 2
Completed NCT01845025 - Study of Safety of Foradil in Patients With Persistent Asthma Phase 4
Not yet recruiting NCT02053402 - Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital Phase 4
Completed NCT01156844 - Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol Phase 2
Completed NCT01078688 - Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma N/A
Completed NCT02026336 - E-nose and Inflammatory Asthma Phenotypes N/A
Withdrawn NCT04271839 - Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients Phase 4
Active, not recruiting NCT04480242 - Asthma Research in Children and Adolescents
Completed NCT02175771 - Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma Phase 3
Completed NCT01147510 - Asthma Control in Elderly Patients With Montelukast Phase 4
Completed NCT03541187 - Cockroach Immunotherapy in Children and Adolescents Phase 2
Completed NCT02040779 - A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma Phase 3
Active, not recruiting NCT05843045 - Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma N/A